BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 25 filers reported holding BIOPHARMX CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $403,000 | -18.4% | 4,584,615 | 0.0% | 0.00% | – |
| Q4 2018 | $494,000 | -73.3% | 4,584,615 | -53.0% | 0.00% | -100.0% |
| Q3 2018 | $1,852,000 | -14.0% | 9,749,615 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $2,153,000 | -4.4% | 9,749,615 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,252,000 | +109.7% | 9,749,615 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,074,000 | -61.5% | 9,749,615 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,788,000 | -38.7% | 9,749,615 | +2.6% | 0.00% | -50.0% |
| Q2 2017 | $4,550,000 | -5.1% | 9,499,615 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,797,000 | +35.0% | 9,499,615 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,553,000 | +24.9% | 9,499,615 | +85.4% | 0.00% | +100.0% |
| Q3 2016 | $2,844,000 | -5.7% | 5,124,615 | +10.4% | 0.00% | -50.0% |
| Q2 2016 | $3,016,000 | -40.4% | 4,640,000 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $5,058,000 | -10.1% | 4,640,000 | +13.2% | 0.00% | 0.0% |
| Q4 2015 | $5,629,000 | – | 4,100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 12,814,286 | $6,471,000 | 1.90% |
| RTW INVESTMENTS, LP | 1,283,951 | $648,000 | 0.17% |
| Sio Capital Management, LLC | 313,717 | $158,000 | 0.09% |
| DAFNA Capital Management LLC | 115,000 | $58,000 | 0.05% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 28,027 | $14,000 | 0.00% |
| Baker Brothers Advisors | 377,295 | $191,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,994 | $55,000 | 0.00% |
| FRANKLIN RESOURCES INC | 9,499,615 | $4,797,000 | 0.00% |
| Moors & Cabot, Inc. | 13,000 | $7,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,274 | $8,000 | 0.00% |